ITCMDBv1
Clinical TrialID 6599

Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher

NCT01416480

Acute Bronchitis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6599
Evidence Id
6599
Core Evidence Id
6599
Source Clinical Trial Id
6587
Herb2 Clinical Trial Id
HBCT006587
Nct Id
NCT01416480
Title
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
Status
Completed
Phase
Phase 3
Study Result
No
Study Condition
Acute Bronchitis
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Theobromine 300mg|DRUG: Levodropropizine 10mg
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
332
Outcome Measure
cough remission rate, cough remission : no cough or 1 short cough in day time, 3 days
Sponsor Collaborator
Ahn-Gook Pharmaceuticals Co.,Ltd
Funded By
INDUSTRY
Location
Hallym University Medical Center, Anyang, Gyeonggi-do, 431-070, Korea, Republic of
Other Id
AG1321001_ACP3
Start Date
2010-05
Primary Completion Date
2011-02
Completion Date
2011-05
First Posted
2011-08-15
Results First Posted
Last Update Posted
2011-08-15
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01416480
Title Cn
Title En
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
Bilingual Status
semi_complete